NovaBridge Biosciences (NBP) Short-term Investments (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Short-term Investments data on file, last reported at $210000.0 in Q4 2025.

• Quarterly Short-term Investments fell 99.8% year-over-year to $210000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $210000.0 (down 99.8% YoY) and the FY2025 annual result came in at $210000.0, down 99.8% from the prior year.
• Short-term Investments steadied at $210000.0 in Q4 2025 per NBP's latest filing, from $210000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $117.8 billion in Q4 2021 and bottomed at $210000.0 in Q2 2025.
• The 5-year median for Short-term Investments is $55.5 million (2024), against an average of $9.1 billion.
• The widest annual swing landed in 2021, when Short-term Investments surged 2475947.76%; it then sank 99.99% in 2022.
• Tracing NBP's Short-term Investments over 5 years: stood at $117.8 billion in 2021, then slumped by 99.99% to $13.6 million in 2022, then soared by 46.2% to $19.9 million in 2023, then jumped by 428.54% to $105.1 million in 2024, then plunged by 99.8% to $210000.0 in 2025.
• Per Business Quant, the three latest NBP Short-term Investments figures stand at $210000.0 (Q4 2025), $210000.0 (Q3 2025), and $210000.0 (Q2 2025).

Peer Comparison